Cell IDx
Helen Snyder is the Director of Business Development & Strategic Partnerships at Cell IDx. Helen received her Ph.D. in immunology from the University of Cambridge, UK, and trained as a postdoctoral fellow at Scripps Research Institute, La Jolla, California. Dr. Snyder has over 30 years of experience in immunology research, reagent development, preclinical development of biotherapeutics, and business development of immunoassay and immunodiagnostic products.
She has held positions as Associate Professor at the University of California, San Diego, as well as Director of Immunology at Dynavax Technologies and key business development roles at both Solulink Biosciences and Cell IDx. Dr. Snyder has over 40 papers and reviews in the areas of immune regulation and vaccine development and holds two patents.
This person is not in any offices
Cell IDx
Cell IDx was founded to be the technology leader in multiplexed cellular immunodiagnostics. They are a privately held biotechnology company committed to developing highly sensitive and specific reagents for research and clinical immunohistochemistry and other immunoassays.